FDA Import Refusal AEK-8079116-1/11/1 — Abbvie Corporation
The FDA refused shipment AEK-8079116-1/11/1 from Abbvie Corporation (Canada) on Dec 30, 2024. The refused product falls under Drugs and Biologics — CYCLOSPORINE (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 30, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62GDY89 CYCLOSPORINE (ANTI-INFLAMMATORY)
- Charges
- 75